PharmaShots | Incisive News in 3 Shots

Subscribe Now

gastrointestinal stromal tumors

Deciphera Reports the US FDA's Acceptance of NDA and Priority Review for Ripretinib to Treat Patients with Advanced Gastrointestinal Stromal Tumors

Deciphera Reports the US FDA's Acceptance of NDA and Priority Review for Ripretinib to Treat Patients with Advanced Gastrointestin...

February 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us